EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome

Mei-Jiao Zhang, De Wu, Li-Fei Yu, Hua Li, Dan Sun, Jian-Min Liang, Xiao-Peng Lu, Rong Luo, Qing-Hui Guo, Rui-Feng Jin, Hong-Wei Zhang, Ge-Fei Lei und 16 weitere

World Journal of Pediatrics · 2025-02 · 21 (2) · 149-158

DOI: 10.1007/s12519-024-00864-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift World Journal of Pediatrics, online erschienen am 02.01.2025. Verfasst von Mei-Jiao Zhang und 27 weiteren Autor:innen. Beteiligte Einrichtung: The First Hospital of Peking University, Beijing, China. Hauptthemen laut MEDLINE: Carbohydrate Metabolism, Inborn Errors, Diet, Ketogenic, Monosaccharide Transport Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucose transporter 1 deficiency syndrome (Glut1DS) was initially reported by De Vivo and colleagues in 1991. This disease arises from mutations in the SLC2A1 and presents with a broad clinical spectrum. It is a treatable neuro-metabolic condition, where prompt diagnosis and initiation of ketogenic dietary therapy can markedly enhance the prognosis. However, due to its rarity, Glut1DS is susceptible to misdiagnosis or missed diagnosis, which can lead to delayed treatment and irreversible dysfunction of the central nervous system. To promote diagnostic awareness and effective treatments, the recommendations for diagnosis and treatment have been developed.

Methods

The panel on Glut1DS included 28 participants from the members of the Ketogenic Diet Professional Committee of the Chinese Epilepsy Association and Chinese experts with extensive experience in managing Glut1DS. All authors extensively reviewed the literature, and the survey results were discussed in detail over several online meetings. Following multiple deliberative sessions, all participants approved the final manuscript for submission.

Results

Early diagnosis and timely treatment of Glut1DS are crucial for improving prognosis. Physicians should be alert to suspiction of this disease if the following clinical manifestations appear: seizures, episodic or persistent movement disorders (often triggered by fasting, fatigue, or exercise), delayed motor and cognitive development. Characteristic clinical presentations may include seizures combined with movement disorders, episodic eye-head movements, and paroxysmal exercise-induced dyskinesia (PED). In these cases, genetic testing should be promptly completed, and a lumbar puncture should be performed if necessary. The ketogenic diet is internationally recognized as the first-line treatment; the earlier it is started, the better the prognosis. It can effectively control seizures and improve motor disorders. Antiepileptic drug treatment is generally ineffective or provides limited symptom improvement before starting the ketogenic diet.

Conclusion

The recommendations provide clinicians with a relatively systematic guide for the rapid identification, diagnosis, and timely treatment of Glut1DS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbohydrate Metabolism, Inborn ErrorsDiet, KetogenicMonosaccharide Transport ProteinsHumansChildFemaleMale

Stichwörter der Autor:innen

ConsensusDiagnosisGlut1DSTreatment

Substanzen

Monosaccharide Transport Proteins

Autor:innen und Institutionen

  • The First Hospital of Peking University, Beijing, China.
  • The First Affiliated Hospital of Anhui Medical University, Anhui, China.
  • Children's Hospital of Fudan University, Shanghai, China.
  • Guangdong Sanjiu Brain Hospital, Guangdong, China.
  • Huazhong University of Science and Technology Tongji Medical College Affiliated Wuhan Children's Hospital, Wuhan, China.
  • Department of Pediatric Neurology, Children's Medical Center, The First Hospital of Jilin University, Changchun, 130021, Jilin, China.

Förderung

  • National Key R&D Program of China

Zitieren

APA

Zhang, M. J., Wu, Yu, L. F., Li, H., Sun, D., Liang, J. M., Lu, X. P., Luo, R., Guo, Q. H., Jin, R. F., Zhang, H. W., Lei, G. F., Sun, R. P., Wang, M., Zhou, Y. F., Wang, Y. Y., Tang, J. H., Hua, Y., Shi, X. L., …, & Bao, X. H. (2025). Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome. World Journal of Pediatrics, 21(2), 149-158. https://doi.org/10.1007/s12519-024-00864-5

Vancouver

Zhang MJ, Wu, Yu LF, Li H, Sun D, Liang JM, et al. Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome. World Journal of Pediatrics. 2025;21(2):149-158. doi:10.1007/s12519-024-00864-5

BibTeX
@article{Zhang2025,
  author = {Zhang, Mei-Jiao and Wu, De and Yu, Li-Fei and Li, Hua and Sun, Dan and Liang, Jian-Min and Lu, Xiao-Peng and Luo, Rong and Guo, Qing-Hui and Jin, Rui-Feng and Zhang, Hong-Wei and Lei, Ge-Fei and Sun, Ruo-Peng and Wang, Man and Zhou, You-Feng and Wang, Ying-Yan and Tang, Ji-Hong and Hua, Ying and Shi, Xu-Lai and Liu, Xiao-Ming and Shi, Xiu-Yu and Yang, Guang and Wang, Hua and Gao, Feng and Jia, Tian-Ming and Wang, Ji-Wen and Liao, Jian-Xiang and Bao, Xin-Hua},
  title = {Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome},
  journal = {World Journal of Pediatrics},
  year = {2025},
  volume = {21},
  number = {2},
  pages = {149--158},
  doi = {10.1007/s12519-024-00864-5}
}
Kostenlos starten →